SCHEMBL2576347

SCHEMBL2576347

CN1CCc2cc(OCCO)c(O)c3c2[C@H]1Cc1ccccc1-3

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.67
DRD3 P35462 1/20 0.67
DRD1 P21728 5/20 0.60
HTR2A P28223 3/20 0.60
HTR7 P34969 2/20 0.60
PNPLA2 Q96AD5 1/20 0.60
HTR2C P28335 1/20 0.60
CYP2D6 P10635 3/20 0.59
CYP2C19 P33261 3/20 0.59
KDM4E B2RXH2 3/20 0.59
ALDH1A1 P00352 3/20 0.59
TP53 P04637 3/20 0.59
CYP3A4 P08684 3/20 0.59
MAPT P10636 3/20 0.59
HPGD P15428 3/20 0.59
CASP1 P29466 3/20 0.59
HSD17B10 Q99714 3/20 0.59
MEN1 O00255 2/20 0.59
CASP7 P55210 2/20 0.59
KMT2A Q03164 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2574124 0.89 DRD2 (0.69) DRD2DRD3DRD1HTR2AHTR7
SCHEMBL29467728 0.85 KDM4E (0.80) DRD2DRD3DRD1HTR2AHTR7
SCHEMBL3936482 0.85 KDM4E (0.80) DRD2DRD3DRD1HTR2AHTR7
SCHEMBL29506709 0.85 KDM4E (0.80) DRD2DRD3DRD1HTR2AHTR7
SCHEMBL4159150 0.85 KDM4E (0.80) DRD2DRD3DRD1HTR2AHTR7
Bromide SCHEMBL11708330 0.84 KDM4E (0.78) DRD2DRD3DRD1HTR2AHTR7
SCHEMBL2578907 0.82 HTR2B (0.61) DRD2DRD3DRD1HTR2ACYP2D6
SCHEMBL2559733 0.82 DRD2 (0.54) DRD2DRD3DRD1HTR2AHTR7
SCHEMBL1692381 0.81 DRD2 (1.00) DRD2DRD3DRD1HTR2AHTR7
SCHEMBL2578252 0.80 DRD2 (0.52) DRD2DRD3DRD1HTR2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011130530-A1 2-ALKOXY-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF THE MCLEAN HOSPITAL CORPORATION (US) 2011-10-20 WO disclosed